AVTR 📈 Avantor - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US05352A1007

AVTR: Chemicals, Reagents, Lab Supplies, Equipment, Instruments, Services

Avantor Inc, a company with a rich history dating back to 1904, operates at the intersection of multiple industries, including biopharma, healthcare, education, government, advanced technologies, and applied materials. With a presence in the Americas, Europe, Asia, the Middle East, and Africa, the company has established itself as a provider of mission-critical products and services. Its portfolio includes a wide range of materials and consumables, such as high-purity chemicals and reagents, lab products, and customized excipients, which are essential for various research and production activities.

The company's product offerings also encompass equipment and instrumentation, including filtration systems, virus inactivation systems, and analytical instruments. These products are designed to support research, development, and production processes in fields like biopharma, healthcare, and education. Additionally, Avantor provides a range of services, including onsite lab and production support, clinical services, equipment procurement, and sourcing. This comprehensive suite of services enables customers to focus on their core activities while relying on Avantor for specialized support.

Avantor's services extend to scientific research support, where the company offers expertise in areas like DNA extraction, bioreactor servicing, and compound management. These services are critical for researchers and scientists working on complex projects, and Avantor's capabilities help accelerate discovery and development. With its headquarters in Radnor, Pennsylvania, and a global presence, Avantor is well-positioned to support customers across various industries and geographies. The company's website, https://www.avantorsciences.com, provides further information on its products, services, and capabilities.

As a publicly traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol AVTR, Avantor is committed to delivering value to its shareholders. With a common stock ISIN of US05352A1007 and a classification under the GICS Sub Industry of Life Sciences Tools & Services, the company operates within a specific segment of the life sciences industry. This focus enables Avantor to concentrate on developing and delivering specialized products and services that meet the evolving needs of its customers, driving growth and innovation in the process.

Additional Sources for AVTR Stock

AVTR Stock Overview

Market Cap in USD 15,035m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC Sub-Industry Life Sciences Tools & Services
IPO / Inception 2019-05-17

AVTR Stock Ratings

Growth 5y 3.59%
Fundamental 14.5%
Dividend -
Rel. Strength Industry -229
Analysts 4.14/5
Fair Price Momentum 19.37 USD
Fair Price DCF 28.40 USD

AVTR Dividends

No Dividends Paid

AVTR Growth Ratios

Growth Correlation 3m -82.8%
Growth Correlation 12m -8.5%
Growth Correlation 5y -2.7%
CAGR 5y 3.08%
CAGR/Mean DD 5y 0.11
Sharpe Ratio 12m -0.26
Alpha -32.48
Beta 0.95
Volatility 29.57%
Current Volume 11025.9k
Average Volume 20d 6053.8k
What is the price of AVTR stocks?
As of December 21, 2024, the stock is trading at USD 21.21 with a total of 11,025,884 shares traded.
Over the past week, the price has changed by -5.02%, over one month by +5.31%, over three months by -21.42% and over the past year by -6.65%.
Is Avantor a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Avantor is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 14.53 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AVTR as of December 2024 is 19.37. This means that AVTR is currently overvalued and has a potential downside of -8.68%.
Is AVTR a buy, sell or hold?
Avantor has received a consensus analysts rating of 4.14. Therefor, it is recommend to buy AVTR.
  • Strong Buy: 9
  • Buy: 7
  • Hold: 6
  • Sell: 0
  • Strong Sell: 0
What are the forecast for AVTR stock price target?
According to ValueRays Forecast Model, AVTR Avantor will be worth about 21.2 in December 2025. The stock is currently trading at 21.21. This means that the stock has a potential downside of -0.19%.
Issuer Forecast Upside
Wallstreet Target Price 27.3 28.8%
Analysts Target Price 24.1 13.4%
ValueRay Target Price 21.2 -0.2%